1. Diabetic Ketoacidosis as an Immune-related Adverse Event from Pembrolizumab in Non–Small Cell Lung Cancer. Issue 6 (July 2017) Authors: Leonardi, Giulia C.; Oxnard, Geoffrey R.; Haas, Andrea; Lang, Joshua P.; Williams, Jonathan S.; Awad, Mark M. Journal: Journal of immunotherapy Issue: Volume 40:Issue 6(2017:Jul./Aug.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Emerging Biomarkers in the Era of Personalized Cancer Medicine. (14th August 2019) Authors: Ricciuti, Biagio; Leonardi, Giulia C.; Brambilla, Marta Journal: Disease markers Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of MET inhibitors on survival among patients with non-small cell lung cancer harboring MET exon 14 mutations: a retrospective analysis. (July 2019) Authors: Awad, Mark M.; Leonardi, Giulia C.; Kravets, Sasha; Dahlberg, Suzanne E.; Drilon, Alexander; Noonan, Sinead A.; Camidge, D. Ross; Ou, Sai-Hong I.; Costa, Daniel B.; Gadgeel, Shirish M.; Steuer, Conor E.; Forde, Patrick M.; Zhu, Viola W.; Fukuda, Yoko; Clark, Jeffrey W.; Jänne, Pasi A.; Mok, Tony;... Journal: Lung cancer Issue: Volume 133(2019) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗